Paid-Up License. Upon the expiration of Pfizer's obligation to pay royalties on Net Sales of Licensed Products as provided in Section 3.7.1, the license granted in Section 5.3.1 shall become an irrevocable, nonexclusive paid-up license.
Paid-Up License. Following expiration of the Agreement pursuant to Section 13.1 hereof, BMI and/or its Sublicensee(s) as applicable, shall have a perpetual, fully paid up non-exclusive license under the rights granted.
Paid-Up License. Upon expiration of any extension hereof under option (a) above or expiration of any one-half royalty patent license under (b) above, Licensee shall have a fully paid-up and perpetual license on the terms set forth herein to use Technology to the same extent as Licensee has been licensed to use Technology immediately prior to such expiration. Said paid-up license shall be as follows:
1. In the event that Licensee elects option (a.) above, such license shall be for applicable Tessera Patent granted for twenty (20) years from the Effective Date; or
2. In the event that Licensee elects option (b) above, such license shall be for applicable Tessera Patent granted for fifteen (15) years from the effective xxxx,
Paid-Up License. Pfizer will have a paid-up, royalty free, non-exclusive license under the grant in Section 6.5 to manufacture, use, sale, offer for sale and import any Product in a country after the expiration of the Royalty Term applicable to such Product in such country.
Paid-Up License. Upon the expiration of the Royalty Term applicable to any Licensed Product in a country, subject to Alnylam Third Party Obligations, Licensee’s and its Affiliates’ licenses under Section 2.1(a) with respect to such Licensed Product in such country shall become a fully paid-up, royalty-free license, with the right to sublicense, to Discover, Develop, Commercialize or Manufacture such Licensed Product in such country.
Paid-Up License. For each country, upon expiration of DPM's obligation to pay royalties hereunder with respect to a Product, DPM shall have a fully paid-up, non-exclusive license under any Signal Know-How or Signal Patent Rights, to make, have made, use, sell, offer for sale and import the applicable Product in that country.
Paid-Up License. Upon expiration of the Royalty Term in any country with respect to a Product (unless such Royalty Term is reinstated as provided in Section 1.42), the selling party shall thereafter have, in perpetuity, a fully paid-up and irrevocable non-exclusive license to make, have made, import, use, offer to sell and sell such Product in such country under the Icagen Technology or Xxxxxx Technology, as the case may be, and Icagen’s interest in Joint Patent Rights and Joint Program Inventions or Xxxxxx’x interest in Joint Patent Rights and Joint Program Inventions, as the case may be, without any accounting to the non-selling party.
Paid-Up License. For each country, upon expiration of LICENSEE's obligation to pay royalties pursuant to Section 4.1, LICENSEE shall have a fully paid-up, non-exclusive license under any Know-How, to make, have made, use and sell Licensed Product in that country.
Paid-Up License. Provided that PNU has satisfied all of its obligations hereunder, including, but not limited to, the obligation to pay royalties hereunder with respect to a particular Product, PNU shall have a paid-up, non-exclusive royalty-free license to make, have made, use, distribute, market, sell and have sold the Compounds and such Product within the Field of Use in each country after the normal expiration of the applicable Country Term.
Paid-Up License. Upon expiration, pursuant to Section 6.8, of P&U's obligation to pay royalties hereunder with respect to a particular Product in a country, the license granted to P&U under Section 2.3 shall terminate as to such Product in such country, and P&U shall automatically be deemed to have been granted a fully paid-up, non-exclusive license under the Versicor Know-how and Versicor Patents to make, have made, distribute, use, import, market, offer for sale and sell such Product in such country.
